Evidence map›Paper›PMID 19776705›Full record

ReviewPolskie Archiwum Medycyny Wewnetrznej2009

Turning laboratory findings into therapy: a marathon goal that has to be reached.

Beatrix Kotlan, David F Stroncek, Francesco M Marincola

Abstract readReview
In one paragraph

Review in Polskie Archiwum Medycyny Wewnetrznej, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 8 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Beatrix KotlanCenter of Surgical and Molecular Tumor Pathology, National Institute of Oncology, Budapest, Hungary.
David F Stroncek
Francesco M Marincola
National Institute of Oncology · HUNational Institutes of Health · US

Funding

Immunogenetic Study of Infectious Diseases and CancerZ01CL002118 · CLC · CLINICAL CENTER · PI MARINCOLA, FRANCESCO M · 2007 to 2008
$1.4M
Immunogenetics of Vaccine TherapyZIACL002115 · CLC · CLINICAL CENTER · PI MARINCOLA, FRANCESCO M · 2009 to 2010
$0k
Development of novel cell and gene therapiesZIACL002120 · CLC · CLINICAL CENTER · PI STRONCEK, DAVID · 2009 to 2025
$0k
Intramural NIH HHS Z01 CL002118
6 · The paper itself

Abstract

The mission of translational research involves difficult tasks to be accomplished for its ultimate goal, i.e., the introduction of novel, effective therapeutic strategies in the clinic to diminish human suffering and cure life-threatening diseases. Translational research (also referred to as translational medicine) facilitates the translation of investment in biomedical research into successful medical treatment. This includes the transfer of diagnostic and therapeutic advances by proving their efficacy in large evidence-based trials. Through the study of humans novel insights about disease are brought back to the laboratory to identify new, observation-based strategies. This "two-way road" ("bench to bedside and bedside to bench") process includes formulating guidelines for drug development and principles for new therapeutic strategies; initiating clinical investigations that provide the biological basis for new therapies, and related clinical trials; defining therapeutic targets and clinical endpoints. It requires a systematic approach beginning with specimen sampling, patient data collection, laboratory investigations, data analysis, preclinical testing, clinical trials, treatment efficacy monitoring, and finally the evaluation of therapeutic result. The marathon well symbolizes the enormous efforts undertaken by clinicians, scientists, regulators, ethicists, patient advocates, drug developers, and others, coordinately attempting to overcome obstacles along this road toward the final "marathon goal in medicine".

Indexed as

Biomedical ResearchChemistry, ClinicalEvidence-Based MedicineHumansInterdisciplinary CommunicationPharmaceutical PreparationsResearch DesignPharmaceutical Preparations

Identifiers

PMID19776705
PMCPMC3528796
OpenAlexW184438507

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.